This drug is a true gamechanger
In the SURMOUNT-1 study, people who took the highest dose of tirzepatide, most of whom had a BMI of about 30 or higher but did not have diabetes, lost about 21% of their body weight during the 72 week study. As researchers point out, for people who have bariatric surgery, typical weight loss is about 25% to 30% of their weight, one or two years after the surgery. In the tirzepatide study, 36% of people taking the highest dose lost 25% or more of their body weight.
this is comparable to bariatric surgery
Jump in the discussion.
No email address required.
Notes -
Hmm... My model is a bit different.
I think it matters which individuals have control of these things and what their incentives are.
And my model is that if I'm a sociopathic CEO I really only care about maximizing the bottom line for the next few years.
I'm not going to bother to dump microplastics into the water supply because the ROI on the cancer rate increase is way too far in the future to benefit me.
More options
Context Copy link